Total Funding
6
Total FundingDebt Financing raised
Growth Score in past quarter
pts
Heat Score 6 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Link Medicine works on creating disease-modifying therapies for neurodegenerative diseases, including Alzheimer's and Parkinson's disease.
About the Company
Link Medicine was launched in 2005 by three men with a shared vision: Peter Lansbury, Link's founder and a leading neuroscience researcher from Harvard University, Ed Rudman, a private investor and philanthropist who less than a decade before had been diagnosed with Parkinson's disease, and Adam Rosenberg, an entrepreneur who years before
saw his grandfather struggle with Parkinson's disease and his grandmother battle Alzheimer's disease.

